FRI0502 Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab

Volume: 75, Pages: 620 - 620
Published: Jun 1, 2016
Abstract
Background null There is no randomized controlled trial data to guide us for the management of Adult Still9s Disease (AOSD) patients refractory to conventional treatments. null Objectives null We herein aimed to analyze retrospectively the treatment results of a series of refractory AOSD patients, who received different biologics. null Methods null We screened our database for patients diagnosed with AOSD between 1987–2015, and reviewed charts...
Paper Details
Title
FRI0502 Biologic Agents in Refractory Adult Still's Disease: Better Response Rates and Acceptable Safety with Anakinra and Tocilizumab
Published Date
Jun 1, 2016
Volume
75
Pages
620 - 620
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.